Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

S2k-Leitlinie „Akute infektiöse Gastroenteritis im Säuglings-, Kindes- und Jugendalter“ – AWMF Registernummer 068-003.

Posovszky C, Backendorf V, Buderus S, Claßen M, Epple HJ, Gruber B, Hauer AC, Hübner J, Keller KM, Koletzko S, Lawrenz B, Schmidt-Choudhury A, Stallmach A, von Both U.

Z Gastroenterol. 2019 Sep;57(9):1077-1118. doi: 10.1055/a-0981-6906. Epub 2019 Sep 16. German. No abstract available.

PMID:
31525800
Free Article
2.

Dataset of clinical, immunohistopathological and laboratory features of patients with MHC II deficiency suffering from enteropathy.

Posovszky C, Sirin M, Jacobsen E, Lorenz M, Schwarz K, Schmidt-Choudhury A, Schütz C, Hönig M, Debatin KM, Schulz A, Möller P, Barth TF.

Data Brief. 2019 Aug 28;26:104446. doi: 10.1016/j.dib.2019.104446. eCollection 2019 Oct.

3.

Buried Foreign Body in the Esophagus - Unusual Cause of Dysphagia in a 2-Year-Old Child.

Witzleben AV, Reiter R, Hoffmann T, Posovszky C.

Klin Padiatr. 2019 Jul;231(4):214-216. doi: 10.1055/a-0942-1838. Epub 2019 Jun 17. No abstract available.

PMID:
31207651
4.

ESBL acquisition in Salmonella spp. and Shigella spp. in the context of systemic cephalosporin treatment.

Spellerberg B, Rabsch W, Pietsch M, Denzer C, Posovszky C, Essig A, Pfeifer Y.

Clin Infect Dis. 2019 Jun 4. pii: ciz468. doi: 10.1093/cid/ciz468. [Epub ahead of print] No abstract available.

PMID:
31165140
5.

Persisting enteropathy and disturbed adaptive mucosal immunity due to MHC class II deficiency.

Posovszky C, Sirin M, Jacobsen E, Lorenz M, Schwarz K, Schmidt-Choudhury A, Rothoeft T, Schuetz C, Hönig M, Debatin KM, Schulz A, Möller P, Barth TF.

Clin Immunol. 2019 Jun;203:125-133. doi: 10.1016/j.clim.2019.04.012. Epub 2019 Apr 24.

PMID:
31028919
6.

Carbon dioxide versus room air for colonoscopy in deeply sedated pediatric patients: a randomized controlled trial.

Kresz A, Mayer B, Zernickel M, Posovszky C.

Endosc Int Open. 2019 Feb;7(2):E290-E297. doi: 10.1055/a-0806-7060. Epub 2019 Jan 30.

7.

Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.

Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, Shah N, Shaoul R, Wolters VM, Rodrigues A, Uhlig HH, Posovszky C, Kolho KL, Jakobsen C, Cohen S, Shouval DS, de Meij T, Martin-de-Carpi J, Richmond L, Bronsky J, Friedman M, Turner D.

J Crohns Colitis. 2018 Apr 27;12(5):630. doi: 10.1093/ecco-jcc/jjx172. No abstract available.

PMID:
29562246
8.

Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis.

Schleker T, Jacobsen EM, Mayer B, Strauss G, Debatin KM, Posovszky C.

Mol Cell Pediatr. 2018 Jan 19;5(1):1. doi: 10.1186/s40348-018-0079-0.

9.

MYO5B, STX3, and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: A mutation update.

Dhekne HS, Pylypenko O, Overeem AW, Zibouche M, Ferreira RJ, van der Velde KJ, Rings EHHM, Posovszky C, van der Sluijs P, Swertz MA, Houdusse A, van IJzendoorn SCD.

Hum Mutat. 2018 Mar;39(3):333-344. doi: 10.1002/humu.23386. Epub 2018 Jan 17. Review. Erratum in: Hum Mutat. 2018 Oct;39(10):1468.

10.

Development and Anatomy of the Enteroendocrine System in Humans.

Posovszky C.

Endocr Dev. 2017;32:20-37. doi: 10.1159/000475729. Epub 2017 Aug 15.

PMID:
28873382
11.

Disrupted apical exocytosis of cargo vesicles causes enteropathy in FHL5 patients with Munc18-2 mutations.

Vogel GF, van Rijn JM, Krainer IM, Janecke AR, Posovszky C, Cohen M, Searle C, Jantchou P, Escher JC, Patey N, Cutz E, Müller T, Middendorp S, Hess MW, Huber LA.

JCI Insight. 2017 Jul 20;2(14). pii: 94564. doi: 10.1172/jci.insight.94564. eCollection 2017 Jul 20.

12.

Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.

Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, Shah N, Shaoul R, Wolters VM, Rodrigues A, Uhlig HH, Posovszky C, Kolho KL, Jakobsen C, Cohen S, Shouval DS, de Meij T, Martin-de-Carpi J, Richmond L, Bronsky J, Friedman M, Turner D.

J Crohns Colitis. 2017 Oct 1;11(10):1230-1237. doi: 10.1093/ecco-jcc/jjx082. Erratum in: J Crohns Colitis. 2018 Apr 27;12(5):630.

PMID:
28605483
13.

Bowel preparation in pediatric colonoscopy: results of an open observational study.

Berger T, Classen M, Engelhardt H, Keller KM, Laass MW, Melchior R, Posovszky C, Rodeck B, Schaper K, Behrens R.

Endosc Int Open. 2016 Jul;4(7):E820-7. doi: 10.1055/s-0042-107789. Epub 2016 Jun 2.

14.

Congenital intestinal diarrhoeal diseases: A diagnostic and therapeutic challenge.

Posovszky C.

Best Pract Res Clin Gastroenterol. 2016 Apr;30(2):187-211. doi: 10.1016/j.bpg.2016.03.004. Epub 2016 Mar 11. Review.

PMID:
27086885
15.

The role of enterocyte defects in the pathogenesis of congenital diarrheal disorders.

Overeem AW, Posovszky C, Rings EH, Giepmans BN, van IJzendoorn SC.

Dis Model Mech. 2016 Jan;9(1):1-12. doi: 10.1242/dmm.022269. Review.

16.

Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.

Herbst SM, Schirmer S, Posovszky C, Jochum F, Rödl T, Schroeder JA, Barth TF, Hehr U, Melter M, Vermehren J.

Mol Cell Probes. 2015 Oct;29(5):291-8. doi: 10.1016/j.mcp.2015.03.001. Epub 2015 Mar 13.

PMID:
25771912
17.
18.
19.

Head Injury in Children: Has a Change in Circumstances Caused an Increase in Treatment Numbers?

Pal'a A, Kapapa M, Posovszky C, Röderer G, König R, Woischneck D, Wirtz CR, Kapapa T.

J Child Neurol. 2015 Aug;30(9):1153-8. doi: 10.1177/0883073814554655. Epub 2014 Nov 4.

PMID:
25370862
20.

Stop the pain: study protocol for a randomized-controlled trial.

Warschburger P, Calvano C, Becker S, Friedt M, Hudert C, Posovszky C, Schier M, Wegscheider K.

Trials. 2014 Sep 11;15:357. doi: 10.1186/1745-6215-15-357.

21.

Health-related quality of life in children with abdominal pain due to functional or organic gastrointestinal disorders.

Warschburger P, Hänig J, Friedt M, Posovszky C, Schier M, Calvano C.

J Pediatr Psychol. 2014 Jan-Feb;39(1):45-54. doi: 10.1093/jpepsy/jst070. Epub 2013 Sep 20.

PMID:
24055816
22.

Age-of-onset-dependent influence of NOD2 gene variants on disease behaviour and treatment in Crohn's disease.

Posovszky C, Pfalzer V, Lahr G, Niess JH, Klaus J, Mayer B, Debatin KM, von Boyen GB.

BMC Gastroenterol. 2013 May 2;13:77. doi: 10.1186/1471-230X-13-77.

23.

Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2/MUNC18-2 mutations.

Stepensky P, Bartram J, Barth TF, Lehmberg K, Walther P, Amann K, Philips AD, Beringer O, Zur Stadt U, Schulz A, Amrolia P, Weintraub M, Debatin KM, Hoenig M, Posovszky C.

Pediatr Blood Cancer. 2013 Jul;60(7):1215-22. doi: 10.1002/pbc.24475. Epub 2013 Feb 4.

PMID:
23382066
24.

[Infantile hepatic hemangiomas: first-line propranolol monotherapy as new treatment strategy?].

Baranowski S, Winkler A, Kunzi-Rapp K, Schaal M, Hempel S, Debatin KM, Posovszky C.

Klin Padiatr. 2012 Oct;224(6):393-5. doi: 10.1055/s-0032-1327622. Epub 2012 Nov 9. German. No abstract available.

PMID:
23143767
25.

Intramural duodenal haematoma after endoscopic biopsy: case report and review of the literature.

Grasshof C, Wolf A, Neuwirth F, Posovszky C.

Case Rep Gastroenterol. 2012 Jan;6(1):5-14. doi: 10.1159/000336022. Epub 2012 Jan 5.

26.

Loss of enteroendocrine cells in autoimmune-polyendocrine-candidiasis-ectodermal-dystrophy (APECED) syndrome with gastrointestinal dysfunction.

Posovszky C, Lahr G, von Schnurbein J, Buderus S, Findeisen A, Schröder C, Schütz C, Schulz A, Debatin KM, Wabitsch M, Barth TF.

J Clin Endocrinol Metab. 2012 Feb;97(2):E292-300. doi: 10.1210/jc.2011-2044. Epub 2011 Dec 7.

PMID:
22162465
27.

Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children.

Decker E, Engelmann G, Findeisen A, Gerner P, Laass M, Ney D, Posovszky C, Hoy L, Hornef MW.

Pediatrics. 2010 Jun;125(6):e1433-40. doi: 10.1542/peds.2009-2260. Epub 2010 May 17.

PMID:
20478942
28.

[Foreign body ingestion in children: recommendation for the diagnostic and therapeutic procedure].

Schmid MB, Posovszky C, Neuwirth F, Galm C, Keck T.

Laryngorhinootologie. 2010 Feb;89(2):73-6. doi: 10.1055/s-0029-1241168. Epub 2010 Feb 12. Review. German.

PMID:
20155646
29.

Novel homozygous AIRE mutation in a German patient with severe APECED.

von Schnurbein J, Lahr G, Posovszky C, Debatin KM, Wabitsch M.

J Pediatr Endocrinol Metab. 2008 Oct;21(10):1003-9.

PMID:
19209622
30.

Residual CD95-pathway function in children with autoimmune lymphoproliferative syndrome is independent from clinical state and genotype of CD95 mutation.

Fuchs H, Posovszky C, Lahr G, van der Werff ten Bosch J, Boehler T, Debatin KM.

Pediatr Res. 2009 Feb;65(2):163-8. doi: 10.1203/PDR.0b013e318191f7e4.

PMID:
18948840
32.

Gangliosides inhibit the development from monocytes to dendritic cells.

Wölfl M, Batten WY, Posovszky C, Bernhard H, Berthold F.

Clin Exp Immunol. 2002 Dec;130(3):441-8.

33.

Plasma from cancer patients featuring a characteristic protein composition mediates protection against apoptosis.

Vejda S, Posovszky C, Zelzer S, Peter B, Bayer E, Gelbmann D, Schulte-Hermann R, Gerner C.

Mol Cell Proteomics. 2002 May;1(5):387-93.

34.

Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.

Herr I, Posovszky C, Di Marzio LD, Cifone MG, Boehler T, Debatin KM.

Oncogene. 2000 Aug 31;19(37):4255-62.

35.

Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis.

Posovszky C, Friesen C, Herr I, Debatin KM.

Leukemia. 1999 Mar;13(3):400-9.

Supplemental Content

Loading ...
Support Center